Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

Similar articles for PubMed (Select 24889736)

1.

Aerosol performance and long-term stability of surfactant-associated liposomal ciprofloxacin formulations with modified encapsulation and release properties.

Cipolla D, Wu H, Gonda I, Chan HK.

AAPS PharmSciTech. 2014 Oct;15(5):1218-27. doi: 10.1208/s12249-014-0155-2. Epub 2014 Jun 3.

2.

Modifying the release properties of liposomes toward personalized medicine.

Cipolla D, Wu H, Gonda I, Eastman S, Redelmeier T, Chan HK.

J Pharm Sci. 2014 Jun;103(6):1851-62. doi: 10.1002/jps.23969. Epub 2014 Apr 8.

PMID:
24715635
3.

Iloprost-containing liposomes for aerosol application in pulmonary arterial hypertension: formulation aspects and stability.

Kleemann E, Schmehl T, Gessler T, Bakowsky U, Kissel T, Seeger W.

Pharm Res. 2007 Feb;24(2):277-87. Epub 2006 Dec 27.

PMID:
17211729
4.

Physical stability and aerosol properties of liposomes delivered using an air-jet nebulizer and a novel micropump device with large mesh apertures.

Elhissi AM, Faizi M, Naji WF, Gill HS, Taylor KM.

Int J Pharm. 2007 Apr 4;334(1-2):62-70. Epub 2006 Oct 21.

PMID:
17123757
5.

Encapsulation into PEG-liposomes does not improve the bioavailability of pulmonary delivered salmon calcitonin.

Swaminathan J, Gobbo OL, Tewes F, Healy AM, Ehrhardt C.

J Aerosol Med Pulm Drug Deliv. 2014 Feb;27(1):1-11. doi: 10.1089/jamp.2013.1049. Epub 2013 Nov 19.

PMID:
24252061
6.

Formulations generated from ethanol-based proliposomes for delivery via medical nebulizers.

Elhissi AM, Karnam KK, Danesh-Azari MR, Gill HS, Taylor KM.

J Pharm Pharmacol. 2006 Jul;58(7):887-94.

PMID:
16805947
7.

In vitro and ex vivo methods predict the enhanced lung residence time of liposomal ciprofloxacin formulations for nebulisation.

Ong HX, Benaouda F, Traini D, Cipolla D, Gonda I, Bebawy M, Forbes B, Young PM.

Eur J Pharm Biopharm. 2014 Jan;86(1):83-9. doi: 10.1016/j.ejpb.2013.06.024. Epub 2013 Jul 10.

PMID:
23851077
8.

Epithelial profiling of antibiotic controlled release respiratory formulations.

Ong HX, Traini D, Bebawy M, Young PM.

Pharm Res. 2011 Sep;28(9):2327-38. doi: 10.1007/s11095-011-0462-1. Epub 2011 May 26.

PMID:
21614637
9.

Physicochemical characterization and stability of rifampicin liposome dry powder formulations for inhalation.

Changsan N, Chan HK, Separovic F, Srichana T.

J Pharm Sci. 2009 Feb;98(2):628-39. doi: 10.1002/jps.21441.

PMID:
18484099
10.

Spray-freeze-dried liposomal ciprofloxacin powder for inhaled aerosol drug delivery.

Sweeney LG, Wang Z, Loebenberg R, Wong JP, Lange CF, Finlay WH.

Int J Pharm. 2005 Nov 23;305(1-2):180-5. Epub 2005 Oct 19.

PMID:
16242277
12.

Nebulized interleukin 2 liposomes: aerosol characteristics and biodistribution.

Khanna C, Waldrep JC, Anderson PM, Weischelbaum RW, Hasz DE, Katsanis E, Klausner JS.

J Pharm Pharmacol. 1997 Oct;49(10):960-71.

PMID:
9364403
13.

Impact of atomization technique on the stability and transport efficiency of nebulized liposomes harboring different surface characteristics.

Lehofer B, Bloder F, Jain PP, Marsh LM, Leitinger G, Olschewski H, Leber R, Olschewski A, Prassl R.

Eur J Pharm Biopharm. 2014 Nov;88(3):1076-85.

PMID:
25460154
14.

Liposomal nanoparticles control the uptake of ciprofloxacin across respiratory epithelia.

Ong HX, Traini D, Cipolla D, Gonda I, Bebawy M, Agus H, Young PM.

Pharm Res. 2012 Dec;29(12):3335-46. doi: 10.1007/s11095-012-0827-0. Epub 2012 Jul 26.

PMID:
22833052
15.

Correlation of drug release with pulmonary drug absorption profiles for nebulizable liposomal formulations.

Beck-Broichsitter M, Rieger M, Reul R, Gessler T, Seeger W, Schmehl T.

Eur J Pharm Biopharm. 2013 May;84(1):106-14. doi: 10.1016/j.ejpb.2012.12.003. Epub 2012 Dec 20.

PMID:
23262166
16.

Nebulization of ultradeformable liposomes: the influence of aerosolization mechanism and formulation excipients.

Elhissi AM, Giebultowicz J, Stec AA, Wroczynski P, Ahmed W, Alhnan MA, Phoenix D, Taylor KM.

Int J Pharm. 2012 Oct 15;436(1-2):519-26. doi: 10.1016/j.ijpharm.2012.06.064. Epub 2012 Jul 13.

PMID:
22796173
17.

A facile method of delivery of liposomes by nebulization.

Desai TR, Hancock RE, Finlay WH.

J Control Release. 2002 Nov 7;84(1-2):69-78.

PMID:
12399169
18.

Cationic vesicles based on biocompatible diacyl glycerol-arginine surfactants: physicochemical properties, antimicrobial activity, encapsulation efficiency and drug release.

Tavano L, Pinazo A, Abo-Riya M, Infante MR, Manresa MA, Muzzalupo R, PĂ©rez L.

Colloids Surf B Biointerfaces. 2014 Aug 1;120:160-7. doi: 10.1016/j.colsurfb.2014.04.009. Epub 2014 May 22.

PMID:
24907585
19.

Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols.

Park CW, Li X, Vogt FG, Hayes D Jr, Zwischenberger JB, Park ES, Mansour HM.

Int J Pharm. 2013 Oct 15;455(1-2):374-92. doi: 10.1016/j.ijpharm.2013.06.047. Epub 2013 Jun 29.

PMID:
23820131
20.

Development of a liposome-based formulation for vitamin K1 nebulization on the skin.

Campani V, Marchese D, Pitaro MT, Pitaro M, Grieco P, De Rosa G.

Int J Nanomedicine. 2014 Apr 10;9:1823-32. doi: 10.2147/IJN.S58365. eCollection 2014.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk